Nicotine Polacrilex Lozenge
Product Images NDC 43598-485

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 43598-485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Nicotine Polacrilex Lozenge 2 mg by Dr. Reddy's Laboratories Inc. The carton features a blue and white design with original flavor indicated, holding 72 lozenges (3 bottles of 24 each). The label highlights it as a stop smoking aid with directions, drug facts, warnings, and usage instructions included on the sides.*

FDA Label Image

Carton2 (Carton2)

Nicotine Polacrilex Lozenge 4 mg packaging label by Dr. Reddy's Laboratories Inc. The label features a blue bottle image with a purple cap, containing 24 lozenges at 4 mg each, with a total of 72 lozenges in the full carton (3 bottles inside). It is labeled as a stop smoking aid in original flavor. The box includes drug facts, warnings, directions, and use instructions, highlighting dosage schedules and safety information for quitting smoking.*

FDA Label Image

Container1 (Container1)

Label for Nicotine Polacrilex Lozenge 2 mg by Dr. Reddy's Laboratories Inc. The label indicates it is a stop smoking aid with original flavor. It shows a package quantity of 24 lozenges, each containing 2 mg of the active ingredient. Instructions and warnings are printed on the sides, along with the NDC number 43598-484-24.*

FDA Label Image

Container2 (Container2)

Packaging label for Nicotine Polacrilex lozenges 4 mg by Dr. Reddy's Laboratories Inc. The label indicates it is a stop smoking aid with original flavor and contains 24 lozenges of 4 mg each. Directions and safety warnings are provided for different age groups and usage instructions.*

FDA Label Image

Figure (Figure)

An instructional diagram for dosing of Nicotine Polacrilex lozenges showing a stepwise schedule over time. Step 1 at the beginning of week 1 recommends 1 lozenge every 1 to 2 hours. Step 2 at the beginning of week 7 recommends 1 lozenge every 2 to 4 hours. Step 3 at the beginning of week 10 recommends 1 lozenge every 4 to 8 hours. The final circle indicates achieving the status of an ex-smoker 12 weeks after the quit date.*

FDA Label Image

Pic1 (Pic1)

An instructional wallet card listing telephone helpline numbers for support. It includes contact numbers for the American Lung Association, American Cancer Society, American Heart Association, and a note about reaching out to a quitting buddy or friend who has quit smoking.*

FDA Label Image

Pic2 (Pic2)

An instructional wallet card titled 'My most important reasons to quit smoking are:' featuring five blank lines for users to personally fill in their reasons. The card is designed as a motivational aid for individuals using Nicotine Polacrilex lozenges.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.